269 related articles for article (PubMed ID: 35753868)
41. Clonal hematopoiesis and inflammation - the perpetual cycle.
Avagyan S; Zon LI
Trends Cell Biol; 2023 Aug; 33(8):695-707. PubMed ID: 36593155
[TBL] [Abstract][Full Text] [Related]
42. Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia.
Tahri S; Mouhieddine TH; Redd R; Lampe L; Nilsson KI; El-Khoury H; Su NK; Nassar AH; Adib E; Bindra G; Abou Alaiwi S; Trippa L; Steensma DP; Castillo JJ; Treon SP; Ghobrial IM; Sperling AS
Blood Adv; 2022 Apr; 6(7):2230-2235. PubMed ID: 34847227
[TBL] [Abstract][Full Text] [Related]
43. Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta-analysis.
Nowakowska MK; Kim T; Thompson MT; Bolton KL; Deswal A; Lin SH; Scheet P; Wehner MR; Nead KT
Am J Hematol; 2022 Apr; 97(4):411-420. PubMed ID: 35015316
[TBL] [Abstract][Full Text] [Related]
44. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
45. Clonal hematopoiesis and its emerging effects on cellular therapies.
von Bonin M; Jambor HK; Teipel R; Stölzel F; Thiede C; Damm F; Kroschinsky F; Schetelig J; Chavakis T; Bornhäuser M
Leukemia; 2021 Oct; 35(10):2752-2758. PubMed ID: 34215849
[TBL] [Abstract][Full Text] [Related]
46. Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.
Awada H; Gurnari C; Visconte V; Durmaz A; Kuzmanovic T; Awada H; Tu ZJ; Cook JR; Bolwell BJ; Sobecks R; Kalaycio M; Bosler D; Maciejewski JP
Leukemia; 2024 Jun; 38(6):1266-1274. PubMed ID: 38684821
[TBL] [Abstract][Full Text] [Related]
47. Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.
Mayerhofer C; Sedrak MS; Hopkins JO; Li T; Tayob N; Faggen MG; Sinclair NF; Chen WY; Parsons HA; Mayer EL; Lange PB; Basta AS; Perilla-Glen A; Lederman RI; Wong AR; Tiwari A; McAllister SS; Mittendorf EA; Gibson CJ; Burstein HJ; Kim AS; Freedman RA; Miller PG
J Natl Cancer Inst; 2023 Aug; 115(8):981-988. PubMed ID: 37042724
[TBL] [Abstract][Full Text] [Related]
48. Factors associated with clonal hematopoiesis and interaction with marrow environment.
Nannya Y
J Bone Miner Metab; 2023 May; 41(3):380-387. PubMed ID: 36346484
[TBL] [Abstract][Full Text] [Related]
49. Environmental influences on clonal hematopoiesis.
King KY; Huang Y; Nakada D; Goodell MA
Exp Hematol; 2020 Mar; 83():66-73. PubMed ID: 31893524
[TBL] [Abstract][Full Text] [Related]
50. Clinical Implications of Clonal Hematopoiesis.
Steensma DP
Mayo Clin Proc; 2018 Aug; 93(8):1122-1130. PubMed ID: 30078412
[TBL] [Abstract][Full Text] [Related]
51. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance).
Craven KE; Ewalt MD
Clin Lab Med; 2023 Dec; 43(4):565-576. PubMed ID: 37865503
[TBL] [Abstract][Full Text] [Related]
52. [Importance of clonal hematopoiesis for hematologic neoplasms].
Götze KS; Lengerke C
Inn Med (Heidelb); 2022 Nov; 63(11):1107-1114. PubMed ID: 36125513
[TBL] [Abstract][Full Text] [Related]
53. Clonal hematopoiesis and autoimmunity.
Kishtagari A; Corty RW; Visconte V
Semin Hematol; 2024 Feb; 61(1):3-8. PubMed ID: 38423847
[TBL] [Abstract][Full Text] [Related]
54. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract][Full Text] [Related]
55. [Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic].
Ziemann F; Metzeler KH
Dtsch Med Wochenschr; 2023 Apr; 148(8):441-450. PubMed ID: 36990116
[TBL] [Abstract][Full Text] [Related]
56. The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma.
DeStefano CB; Gibson SJ; Sperling AS; Richardson PG; Ghobrial I; Mo CC
Semin Oncol; 2022 Feb; 49(1):19-26. PubMed ID: 35105451
[TBL] [Abstract][Full Text] [Related]
57. Spatial Mapping of Hematopoietic Clones in Human Bone Marrow.
Young AL; Davis HC; Cox MJ; Parsons TM; Burkart SC; Bender DE; Sun L; Oh ST; Challen GA
Blood Cancer Discov; 2024 May; 5(3):153-163. PubMed ID: 38421682
[TBL] [Abstract][Full Text] [Related]
58. Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones.
Osman AEG; Mencia-Trinchant N; Saygin C; Moma L; Kim A; Housman G; Pozsgai M; Sinha E; Chandra P; Hassane DC; Sboner A; Sangani K; DiNardi N; Johnson C; Wallace SS; Jabri B; Luu H; Guzman ML; Desai P; Godley LA
Blood Adv; 2023 May; 7(9):1910-1914. PubMed ID: 36453641
[TBL] [Abstract][Full Text] [Related]
59. CHIP: is clonal hematopoiesis a surrogate for aging and other disease?
Gondek LP
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):384-389. PubMed ID: 34889429
[TBL] [Abstract][Full Text] [Related]
60. The impact of age and number of mutations on the size of clonal hematopoiesis.
Wang K; Zhang W; Yi L; Zhao M; Li PY; Fu MH; Lin R; Zhu YM; Li JF; Yang WP; Fang H; Chen Z; Cai WW; Ren RB
Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2319364121. PubMed ID: 38359296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
